Samuel Gandy

The World

Abiraterone shows promise in prostate cancer fight, Dimebon for Alzheimer’s

Environment

A 21-patient study has shown that the drug abiraterone can stop the testosterone that feeds prostate cancer. A larger international clinical trial is underway to test the drug before it can be deemed a ‘miracle drug. Also, Dimebon, once used as an antihistamine, has been found to improve cognitive abilities for Alzheimer’s patients.

Tell us about your experience accessing The World

We want to hear your feedback so we can keep improving our website, theworld.org. Please fill out this quick survey and let us know your thoughts (your answers will be anonymous). Thanks for your time!

We respect your time, attention and privacy

This is a news website, not a click casino. We do NOT employ deceptive behaviors, display annoying ads or use third party cookies and trackers to monetize your visit or help advertisers track you across the internet.

Simply, we ask that you would consider a donation to support the journalism we produce every weekday. Thank you.